.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
AstraZeneca
Chinese Patent Office
Healthtrust
Citi
Colorcon
Teva
Medtronic
Julphar
Cerilliant

Generated: December 13, 2017

DrugPatentWatch Database Preview

PROMETHAZINE VC W/ CODEINE Drug Profile

« Back to Dashboard

When do Promethazine Vc W/ Codeine patents expire, and when can generic versions of Promethazine Vc W/ Codeine launch?

Promethazine Vc W/ Codeine is a drug marketed by Cenci and Wockhardt and is included in two NDAs.

The generic ingredient in PROMETHAZINE VC W/ CODEINE is codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride. There are nineteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
CenciPROMETHAZINE VC W/ CODEINEcodeine phosphate; phenylephrine hydrochloride; promethazine hydrochlorideSYRUP;ORAL088816-001Nov 22, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
WockhardtPROMETHAZINE VC W/ CODEINEcodeine phosphate; phenylephrine hydrochloride; promethazine hydrochlorideSYRUP;ORAL088896-001Jan 4, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Deloitte
Fish and Richardson
Dow
Moodys
Daiichi Sankyo
Johnson and Johnson
Cipla
Citi
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot